Trial Site Detail

 

Drug:
Imatinib
Trial:
Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Allgemeines Krankenhaus

     
Vienna , A1090
Austria

 

Principal Investigator:
Johannes Zacherl, MD
Contact:
43-140-400-5622
Activation Status of this Site:
Closed
Notes about this Site:
Allgemeines Krankenhaus Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.